angiotensin ii has been researched along with hexarelin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernareggi, M; Berti, F; De Gennaro Colonna, V; Müller, EE; Rossoni, G | 1 |
| Bernareggi, M; Berti, F; De Gennaro Colonna, V; Müller, EE; Polvani, GL; Rossoni, G | 1 |
| Bernareggi, M; Berti, F; De Gennaro Colonna, V; Deghenghi, R; Locatelli, V; Müller, EE; Rossoni, G; Schweiger, F; Torsello, A | 1 |
| Berti, F; De Gennaro Colonna, V; Müller, E; Rossoni, G | 1 |
| Asotra, K; Cao, JM; Chen, C; Chen, MC; Ni, C; Pang, JJ; Xu, RK; Xu, XB; Zhu, WL | 1 |
| Agbo, E; Li, MX; Massaro, J; Saahene, RO; Tian, GZ; Wang, YQ | 1 |
6 other study(ies) available for angiotensin ii and hexarelin
| Article | Year |
|---|---|
Cardiac ischemia and impairment of vascular endothelium function in hearts from growth hormone-deficient rats: protection by hexarelin.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Animals; Antibodies; Coronary Circulation; Endothelium, Vascular; Growth Hormone; Growth Hormone-Releasing Hormone; Growth Substances; Immunization, Passive; In Vitro Techniques; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Oligopeptides; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents; Ventricular Pressure | 1997 |
Protectant activity of hexarelin or growth hormone against postischemic ventricular dysfunction in hearts from aged rats.
Topics: 6-Ketoprostaglandin F1 alpha; Aging; Angiotensin II; Animals; Growth Hormone; Heart; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Oligopeptides; Protective Agents; Rats; Rats, Sprague-Dawley; Ventricular Dysfunction, Left | 1998 |
Growth hormone-independent cardioprotective effects of hexarelin in the rat.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Animals; Creatine Kinase; Growth Hormone; Heart; In Vitro Techniques; Insulin-Like Growth Factor I; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Oligopeptides; Rats; Rats, Sprague-Dawley | 1999 |
Hexarelin exhibits protective activity against cardiac ischaemia in hearts from growth hormone-deficient rats.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin II; Animals; Antibodies; Area Under Curve; Body Weight; Coronary Vessels; Cytoprotection; Endothelium, Vascular; Growth Hormone; Growth Hormone-Releasing Hormone; Heart Ventricles; Male; Myocardial Ischemia; Myocardial Reperfusion; Oligopeptides; Organ Size; Perfusion; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents; Vasodilation | 1998 |
Hexarelin protects rat cardiomyocytes from angiotensin II-induced apoptosis in vitro.
Topics: Angiotensin II; Animals; Animals, Newborn; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspases; Cells, Cultured; Coloring Agents; Dose-Response Relationship, Drug; Electrophoresis, Agar Gel; Flow Cytometry; Growth Substances; In Situ Nick-End Labeling; Myocytes, Cardiac; Oligopeptides; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Tetrazolium Salts; Thiazoles; Vasoconstrictor Agents | 2004 |
Hexarelin protects cardiac H9C2 cells from angiotensin II-induced hypertrophy
Topics: Angiotensin II; Animals; Autophagosomes; Autophagy; Cardiomegaly; Cell Line; Cell Survival; Metabolic Networks and Pathways; Myocytes, Cardiac; Oligopeptides; Oxidative Stress; Protective Agents; Rats; Signal Transduction; TOR Serine-Threonine Kinases | 2019 |